United States · 
Who invested in Carmine Therapeutics?
Carmine Therapeutics's investors include Huagai Capital, Cystic Fibrosis Foundation, EVX Ventures and Simcere Pharmaceuticals.
United States · Series A startup
Who invested in Carmine Therapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 2 sources
- Latest round
- Series AOct 2022
- Investors
- 4
The rounds
- Oct 2022Series AAmount undisclosed
Reported by Firms' own news pages and 1 otherSEC filing: $14M sold, first sale Aug 2022
Founders and team
From the SEC filings it signed: 1 on the team.
- Donald HautExecutive Officer, Directori
On the board, as filediElan EzicksonHarvey LodishLin Xiangqian
Everyone who backed them
Simcere PharmaceuticalsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Carmine Therapeutics
How much has Carmine Therapeutics raised?
Carmine Therapeutics has raised 1 round since 2022, none with a disclosed amount.
When did Carmine Therapeutics last raise?
Carmine Therapeutics's most recent round was a Series A in Oct 2022.
Who backed Carmine Therapeutics first?
Carmine Therapeutics's first round on record, in Oct 2022, was backed by Huagai Capital, Cystic Fibrosis Foundation and EVX Ventures and 1 others.
What stage is Carmine Therapeutics at?
Carmine Therapeutics's latest named round is a Series A, in Oct 2022.
Where is Carmine Therapeutics based?
Carmine Therapeutics is based in the United States.
Companies like Carmine Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.